SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-19-019674
Filing Date
2019-10-16
Accepted
2019-10-16 18:59:03
Documents
2
Period of Report
2019-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1786
2 POWER OF ATTORNEY poa_peterson.htm EX-24.1 8443
  Complete submission text file 0001567619-19-019674.txt   11633
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Peterson Amy C. (Reporting) CIK: 0001682735 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 191153621